NCT06239506View on ClinicalTrials.gov

Novel Brominated and Organophosphate Flame Retardants and Type 2 Diabetes

RecruitingOBSERVATIONAL
Enrollment

340

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Type 2 DiabetesNovel Brominated Flame RetardantsOrganophosphate Flame RetardantsFasting Plasma Glucose
Interventions
OTHER

no intervention

no intervention

Trial Locations (1)

250000

RECRUITING

The First Affiliated Hospital of Shandong First Medical University, Jinan

All Listed Sponsors
lead

Xiaoling Guan

OTHER